Changes to MHRA payment of fees

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that paying for medicines licences, clinical trials and clinical investigations is changing from 1 April.

31st March 2017

Instead of paying in advance, a new ‘Pay on Invoice’ process will streamline the way MHRA manages a range of applications.

MHRA is committed to reducing the regulatory burden and improving the process for licence applications.

From 1 April those making applications will no longer need to attach proof of payment making the end-to-end process simpler, easier and quicker.

The benefits of the new process include removing the need to work out complex fees and reducing the chance of applications being rejected for incorrect payment details.

Additionally the simplified payment process should result in fewer delays and make it easier for companies to reconcile financial records and accounts.

Please read more at:

For more information or an estimate, contact us »

Who we help: